Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial
- PDF / 1,149,914 Bytes
- 11 Pages / 595.276 x 790.866 pts Page_size
- 45 Downloads / 167 Views
ORIGINAL
Health‑related quality of life in survivors of septic shock: 6‑month follow‑up from the ADRENAL trial Naomi E. Hammond1,2* , Simon R. Finfer1,2, Qiang Li1, Colman Taylor1, Jeremy Cohen3, Yaseen Arabi4, Rinaldo Bellomo5, Laurent Billot1, Meg Harward1,6, Christopher Joyce6,14, Colin McArthur7, John Myburgh1,8, Anders Perner9, Dorrilyn Rajbhandari1, Andrew Rhodes10, Kelly Thompson1, Steve Webb11,12 and Balasubramanian Venkatesh1,6,13,14 on behalf of the ADRENAL Trial Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group © 2020 Springer-Verlag GmbH Germany, part of Springer Nature
Abstract Purpose: To investigate the impact of hydrocortisone treatment and illness severity on health-related quality of life (HRQoL) at 6 months in septic shock survivors from the ADRENAL trial. Methods: Using the EuroQol questionnaire (EQ-5D-5L) at 6 months after randomization we assessed HRQoL in patient subgroups defined by hydrocortisone or placebo treatment, gender, illness severity (APACHE II
Data Loading...
